Eli Lilly & Co. (LLY) Misses Q2 EPS by 46c, Revenue Misses
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $1,213.91 --0%
Revenue Growth %: +31.7%
Financial Fact:
Acquired in-process research and development: 0
Today's EPS Names:
CRMT, PKE, More
Revenue Growth %: +31.7%
Financial Fact:
Acquired in-process research and development: 0
Today's EPS Names:
CRMT, PKE, More
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q2 EPS of $1.25, $0.46 worse than the analyst estimate of $1.71. Revenue for the quarter came in at $6.49 billion versus the consensus estimate of $6.85 billion.
GUIDANCE:
Eli Lilly & Co. sees FY2022 EPS of $7.90-$8.05, versus the consensus of $8.08.
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- S&P Global releases recast financials after Mobility spin-off
- Solstice acquiring Element Solutions in $14.5B cash and stock deal
- A Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics Opportunity
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
